Mounjaro and Wegovy in Northern Ireland: what to know before you start

If you've searched for Mounjaro or Wegovy in Northern Ireland, you've probably noticed the information online is a mix of NHS eligibility rules, private clinic marketing, and a lot of general chatter that doesn't quite explain how the two fit together. Here's a straightforward look at what each medicine is, how NHS and private access actually differ, and what's worth asking before you start, whether your prescription comes from a GP, an NHS weight management service, or a private clinic. 

Mounjaro and Wegovy are not the same medicine 

Mounjaro (tirzepatide) and Wegovy (semaglutide) are both prescription-only weight management medicines, but they're different drugs, made by different manufacturers, with different NICE guidance behind each one. Neither is available over the counter, and neither can be supplied without a valid prescription from a registered prescriber, and that applies whether the prescription comes through the NHS or privately. 

NHS access, and why the two medicines look different on paper 

For semaglutide (Wegovy), NICE's technology appraisal (TA875) sets out fairly specific criteria: it's generally recommended for adults with a BMI of at least 35 kg/m², or 30 to 34.9 kg/m² if they meet specialist referral criteria, and lower BMI thresholds (usually reduced by 2.5 kg/m²) apply for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds, reflecting different health risk at the same BMI. People also need at least one weight-related health condition, and treatment is only recommended within a specialist tier 3 or tier 4 weight management service that provides ongoing multidisciplinary support. The medicine is meant to be used alongside a reduced-calorie diet and increased activity, not as a standalone treatment. NICE also sets a maximum treatment duration of two years, with progress reviewed at six months. 

Tirzepatide (Mounjaro) has followed a different, phased path onto the NHS. Rather than opening up nationally all at once, GP practices have been asked to identify and contact patients who meet the current phase's criteria, reported by NHS integrated care systems as a BMI of 40 kg/m² or above, together with at least four of five specified weight-related conditions (type 2 diabetes, high blood pressure, cardiovascular disease, obstructive sleep apnoea, and high cholesterol/dyslipidaemia). Being contacted by a GP practice isn't the same as being prescribed straight away. Access is also conditional on engaging with the wrap-around lifestyle support that comes with it, and the rollout is designed to widen gradually over several years rather than all at once. 

The practical upshot: two people with a similar BMI could have quite different NHS access to each medicine, purely because the two appraisals set different thresholds and the rollout for one is still being phased in. If you're not sure where you stand, your GP practice is the right place to ask. This article can only describe the general framework, not confirm your individual eligibility. 

Private access works differently

A lot of people in Northern Ireland access these medicines through a private prescriber or clinic rather than through the NHS pathway above. Sometimes it's because they don't meet current NHS criteria, sometimes because they'd rather not wait for a phased rollout to reach them. A private prescription still has to come from a registered prescriber who has properly assessed you; a pharmacy dispensing it is checking that the prescription is valid and appropriate to supply, not re-running the clinical assessment itself. 

123 Chem dispenses private prescriptions for weight management medicines written by a patient's own private prescriber or clinic. We're a dispensing pharmacy for this service, not the prescriber. See our Weight Loss & Weight Management page for how that works in practice, including for patients travelling from outside Northern Ireland.  

Questions worth asking before you start 

• Which specific medicine has been prescribed, and why that one rather than an alternative. Your prescriber is the right person to explain this, not a pharmacy or a blog article. 

• What ongoing monitoring or lifestyle support is included alongside the prescription, since NICE guidance treats these medicines as part of a wider plan, not a standalone fix. 

• How a prescription will be renewed or reviewed over time, particularly if you're accessing it privately rather than through an NHS service with built-in review points. 

• Whether your GP is aware you're taking it, so your wider health record stays complete and accurate. 

How 123 Chem can help 

Whether your prescription comes from your GP, an NHS weight management service, or a private clinic, our pharmacists can dispense it and talk through practical questions about taking the medicine day to day. Get in touch with your nearest branch, or read more on our Weight Loss & Weight Management page. 

This article is general information, not medical advice, and doesn't replace an assessment by your GP or prescriber. Eligibility criteria for NHS access are set nationally and can change. Always check current guidance rather than relying on this page alone.